Skip to Content
Merck
All Photos(4)

Key Documents

View All Documentation

79622

Sigma-Aldrich

Phosphoric acid

puriss. p.a., crystallized, ≥99.0% (T)

Synonym(s):

Orthophosphoric acid

Sign Into View Organizational & Contract Pricing
All Photos(4)

About This Item

Linear Formula:
H3PO4
CAS Number:
7664-38-2
Molecular Weight:
98.00
Beilstein:
1921286
EC Number:
231-633-2
MDL number:
MFCD00011340
UNSPSC Code:
12352106
PubChem Substance ID:
329768533
NACRES:
NA.21

vapor density

3.4 (vs air)

vapor pressure

2.2 mmHg ( 20 °C)
5 mmHg ( 25 °C)

grade

puriss. p.a.

Assay

≥99.0% (T)

form

powder or crystals

quality

crystallized

impurities

≤0.002% KMnO4-reducing matter (as O)

bp

158 °C (lit.)

mp

~40 °C (lit.)
~40 °C

solubility

water: 850 g/L at 20 °C

density

1.685 g/mL at 25 °C (lit.)

anion traces

chloride (Cl-): ≤5 mg/kg
nitrate (NO3-): ≤5 mg/kg
phosphite, hypophosphite (as H3PO3): ≤500 mg/kg
sulfate (SO42-): ≤30 mg/kg

cation traces

As: ≤1 mg/kg
Ca: ≤10 mg/kg
Cd: ≤1 mg/kg
Co: ≤1 mg/kg
Cr: ≤1 mg/kg
Cu: ≤1 mg/kg
Fe: ≤10 mg/kg
K: ≤5 mg/kg
Mg: ≤1 mg/kg
Mn: ≤1 mg/kg
Na: ≤50 mg/kg
Ni: ≤1 mg/kg
Pb: ≤1 mg/kg
Zn: ≤1 mg/kg

SMILES string

OP(O)(O)=O

InChI

1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)

InChI key

NBIIXXVUZAFLBC-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Phosphoric acid (H3PO4) is also known as orthophosphoric acid. It serves as an intermediary or reagent in various manufacturing processes. Phosphoric acid is found in fertilizers, detergents, and other household cleaning products.
The product is crystalline phosphoric acid.

Application

Phosphoric acid has been employed as an oxidation reagent in a study.1 It may be used in the preparation of ammonium phosphate.
Phosphoric acid is used:
  • As a catalyst in the nucleophilic addition to imines.
  • In the synthesis of porous phosphoric acid-based geopolymers.
  • In the synthesis of mono-alkyl phosphates from simple aliphatic alcohols in the presence of acetic anhydride activator.

Other Notes

Concentrated phosphoric acid is approx. 85% H3PO4 (aqueous).

Caution

product may become solid, becomes liquid on heating to 50°C

Pictograms

CorrosionExclamation mark
GHS05,GHS07

Signal Word

Danger

Hazard Statements

H290,H302,H314

Hazard Classifications

Acute Tox. 4 Oral - Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B

Storage Class Code

8A - Combustible corrosive hazardous materials

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Christian Reichel et al.
Drug testing and analysis, 9(11-12), 1721-1730 (2017-09-21)
Luspatercept (ACE-536, ACVR2B-Fc), a fusion protein consisting of the extracellular domain of ActRIIB receptor and the Fc-part of human immunoglobulin G1 (IgG1), is currently under clinical development (Phase III). It stimulates the formation of red blood cells and hence may
Eagleson M.
Concise Encyclopedia Chemistry, 67-67 (1994)
Alessio Ciulli et al.
Journal of medicinal chemistry, 49(16), 4992-5000 (2006-08-04)
Mapping interactions at protein-ligand binding sites is an important aspect of understanding many biological reactions and a key part of drug design. In this paper, we have used a fragment-based approach to probe "hot spots" at the cofactor-binding site of
Alex W Gregory et al.
Organic letters, 15(17), 4330-4333 (2013-08-30)
A highly enantioselective hydroamination/N-sulfonyliminium cyclization cascade is reported using a combination of gold(I) and chiral phosphoric acid catalysts. An initial 5-exo-dig hydroamination and a subsequent phosphoric acid catalyzed cyclization process provide access to complex sulfonamide scaffolds in excellent yield and
W M Fennis et al.
Journal of dental research, 93(1), 36-41 (2013-10-25)
The objective of this randomized control trial was to compare the five-year clinical performance of direct and indirect resin composite restorations replacing cusps. In 157 patients, 176 restorations were made to restore maxillary premolars with Class II cavities and one
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service